248 related articles for article (PubMed ID: 9151858)
1. Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3.
Sandberg M; Hammerschmidt W; Sugden B
J Virol; 1997 Jun; 71(6):4649-56. PubMed ID: 9151858
[TBL] [Abstract][Full Text] [Related]
2. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
[TBL] [Abstract][Full Text] [Related]
3. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
[TBL] [Abstract][Full Text] [Related]
4. Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs.
Brodeur SR; Cheng G; Baltimore D; Thorley-Lawson DA
J Biol Chem; 1997 Aug; 272(32):19777-84. PubMed ID: 9242637
[TBL] [Abstract][Full Text] [Related]
5. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
[TBL] [Abstract][Full Text] [Related]
6. LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling.
Kaykas A; Worringer K; Sugden B
J Virol; 2002 Nov; 76(22):11551-60. PubMed ID: 12388716
[TBL] [Abstract][Full Text] [Related]
7. Transmembrane domains 1 and 2 of the latent membrane protein 1 of Epstein-Barr virus contain a lipid raft targeting signal and play a critical role in cytostasis.
Coffin WF; Geiger TR; Martin JM
J Virol; 2003 Mar; 77(6):3749-58. PubMed ID: 12610149
[TBL] [Abstract][Full Text] [Related]
8. The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain.
Coffin WF; Erickson KD; Hoedt-Miller M; Martin JM
Oncogene; 2001 Aug; 20(38):5313-30. PubMed ID: 11536044
[TBL] [Abstract][Full Text] [Related]
9. Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression.
Miller WE; Cheshire JL; Raab-Traub N
Mol Cell Biol; 1998 May; 18(5):2835-44. PubMed ID: 9566902
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation.
Fotin-Mleczek M; Henkler F; Hausser A; Glauner H; Samel D; Graness A; Scheurich P; Mauri D; Wajant H
J Biol Chem; 2004 Jan; 279(1):677-85. PubMed ID: 14557256
[TBL] [Abstract][Full Text] [Related]
11. TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation.
He L; Grammer AC; Wu X; Lipsky PE
J Biol Chem; 2004 Dec; 279(53):55855-65. PubMed ID: 15383523
[TBL] [Abstract][Full Text] [Related]
12. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
[TBL] [Abstract][Full Text] [Related]
13. Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.
Duckett CS; Gedrich RW; Gilfillan MC; Thompson CB
Mol Cell Biol; 1997 Mar; 17(3):1535-42. PubMed ID: 9032281
[TBL] [Abstract][Full Text] [Related]
14. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.
Pullen SS; Dang TT; Crute JJ; Kehry MR
J Biol Chem; 1999 May; 274(20):14246-54. PubMed ID: 10318845
[TBL] [Abstract][Full Text] [Related]
15. TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.
Eliopoulos AG; Waites ER; Blake SM; Davies C; Murray P; Young LS
J Virol; 2003 Jan; 77(2):1316-28. PubMed ID: 12502848
[TBL] [Abstract][Full Text] [Related]
16. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.
Devergne O; Cahir McFarland ED; Mosialos G; Izumi KM; Ware CF; Kieff E
J Virol; 1998 Oct; 72(10):7900-8. PubMed ID: 9733827
[TBL] [Abstract][Full Text] [Related]
17. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins.
Gedrich RW; Gilfillan MC; Duckett CS; Van Dongen JL; Thompson CB
J Biol Chem; 1996 May; 271(22):12852-8. PubMed ID: 8662842
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
20. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex.
Fries KL; Miller WE; Raab-Traub N
Virology; 1999 Nov; 264(1):159-66. PubMed ID: 10544141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
